Gene-edited CAR T cells caused no adverse effects in three cancer patients who participated in a recent Phase I Clinical trial, the first of its kind in the US. The
Gene-edited CAR T cells caused no adverse effects in three cancer patients who participated in a recent Phase I Clinical trial, the first of its kind in the US. The